Vollmer K, Holst JJ, Baller B, et al
Aim for at least 30 minutes of moderate exercise most days of the week
The seven drugs that are currently considered GLP-1 receptor agonists include: Dulaglutide (Trulicity) Tirzepatide (Mounjaro, Zepbound) Exenatide extended-release (Bydureon) Exenatide (Byetta) Semaglutide injection (Ozempic, Wegovy) Semaglutide tablet (Rybelsus) Liraglutide (Victoza, Saxenda) Lixisenatide (Adlyxin) If all of these drugs influence GLP-1 in similar ways, what makes each of them unique
Tirzepatide also provides strong fatty liver clearance, but not at the sheer velocity demonstrated by the triple agonist
The concern is consistency
Some peptides create biochemical conditions that make other peptides more effective